Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

Clinical trial NCT00320424 · COMPLETED

Trial details

NCT number: NCT00320424
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thromboembolism

Start date: 2006-02-16
Primary completion: 2006-10-26
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.